Alpha 2.0
Login Register
» Authors » Fatma Jendoubi

Fatma Jendoubi

Explore the profile of Fatma Jendoubi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 77
Followers 0
Related Specialties
Dermatology
General Surgery
General Medicine
Top 10 Co-Authors
Carle Paul
Cristina Bulai Livideanu
Maria Polina Konstantinou
Mourad Mokni
Marie Tauber
Salama Hegazy
Asmahane Souissi
Emilie Tournier
Mathilde Negretto
Mohamed Raouf Dhaoui
Published In
Presse Med
Dermatol Ther
Br J Dermatol
Skin Appendage Disord
Orphanet J Rare Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Treatment of familial glomangiomatosis with Nd:YAG laser: a case report
Baqays A, Livideanu C, Mazereeuw-Hautier J, Alkhalaf H, Jendoubi F
J Cosmet Laser Ther . 2024 Aug; 26(1-4):81-82. PMID: 39171935
Familial glomangiomatosis is a rare autosomal dominant vascular malformation caused by a mutation in the glomulin GLMN gene. It is characterized by the appearance of multiple glomus tumors composed of...
2.
Efficacy and safety of dupilumab in bullous pemphigoid: a retrospective multicentric study of 36 patients
Moghadam P, Tancrede E, Bouaziz J, Kallout J, Bedane C, Begon E, et al.
Br J Dermatol . 2023 May; 189(2):244-246. PMID: 37155583
No abstract available.
3.
Severe pemphigoid nodularis successfully treated with dupilumab
Jendoubi F, Bost C, Tournier E, Paul C, Konstantinou M
Dermatol Ther . 2022 Jul; 35(9):e15727. PMID: 35861645
No abstract available.
4.
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review
Regnault M, Shourick J, Jendoubi F, Tauber M, Paul C
Am J Clin Dermatol . 2022 Apr; 23(4):433-447. PMID: 35489008
Background: The decision of when to discontinue systemic treatment after achieving remission in psoriasis is an important question. In this systematic review, we sought to evaluate time to relapse after...
5.
Longer dupilumab dosing intervals in adult patients with atopic dermatitis: experience from a French multicentre retrospective cohort study
Jendoubi F, Shourik J, Seneschal J, Giordano-Labadie F, Raison-Peyron N, Du-Thanh A, et al.
Br J Dermatol . 2022 Apr; 187(4):602-603. PMID: 35481677
No abstract available.
6.
Bullous pemphigoid associated with Grover disease: a specific toxicity of anti-PD-1 therapies?
Jendoubi F, Sibaud V, Meyer N, Tournier E, Fortenfant F, Livideanu C, et al.
Int J Dermatol . 2022 Jan; 61(6):e200-e202. PMID: 35073414
No abstract available.
7.
A Multicentre Randomised Controlled Study Evaluating the Effect of a Standardised Education Programme on Quality of Life, Disease Severity, and Disease Knowledge in Patients with Moderate-To-Severe Psoriasis: The EDUPSO Study
Jendoubi F, Balica S, Richard M, Chiaverini C, Bernier C, Quiles N, et al.
Dermatology . 2021 Dec; 238(4):630-639. PMID: 34883480
Background: Psoriasis is a chronic inflammatory skin disease that has a profound effect on health-related quality of life (HRQoL). Patient education programmes may help patients to gain life-long control over...
8.
Efficacy and tolerability of long-pulse Alexandrite laser hair removal for hidradenitis suppurativa
Fradet M, Livideanu C, Katoulis A, Hegazy S, Bouznad A, Jendoubi F, et al.
Eur J Dermatol . 2021 Jun; PMID: 34106051
No abstract available.
9.
Tapinarof-induced folliculitis: The paradigm of activation of the aryl hydrocarbon signaling pathway
Konstantinou M, Jendoubi F, Hegazy S, Bouznad A, Tauber M, Bulai-Livideanu C, et al.
J Am Acad Dermatol . 2021 Mar; 85(1):e37-e38. PMID: 33677000
No abstract available.
10.
Neuropsychiatric, cognitive and sexual impairment in mastocytosis patients
Jendoubi F, Severino-Freire M, Negretto M, Arbus C, Paul C, Livideanu C
Orphanet J Rare Dis . 2021 Mar; 16(1):118. PMID: 33673856
Background: Mastocytosis is a rare disease characterised by the accumulation and/or proliferation of abnormal mast cells (MCs) in one or several organs. It may present with a number of different...